Clinical Trial Update: Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial investigates the combination of targeted radiotherapy with Venetoclax and ASTX-727 for adults with newly diagnosed acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ASTX-727 (decitabine/cedazuridine)
• Venetoclax (venetoclax)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: SUSPENDED